Ironing out the cancer nursing challenges during COVID-19: a best practice discussion 1st December 2020 12-1.30 - https://www.eventbrite.co.uk/e/cancer-nursing-practice-webinar-tickets-127714508533
The Christie School of Oncology Education have changed to 'virtual' learning and live streaming for forthcoming educational programmes.
To access information click here https://www.christie.nhs.uk/education/continuing-professional-development/study-days-and-conferences
To access the information, you will need to use ‘Learnzone’. You don’t need to be a Macmillan Professional to do this, you just need to create an account from the Learnzone landing page by registering with an e-mail address and creating a password if you don’t already have an account.
The Staff and SAfety EFfects of Epidemics (SSAFE) project is a longitudinal study looking at the wellbeing of ALL healthcare workers publishing live data of healthcare staff safety, psychological wellbeing and burnout. Imperial have recruited approximately 300 people and have been able to publish more data to a custom-build dashboard: https://www.pansurg.org/ssafe_data/
Introduction to Haemato-Oncology Nursing, What you need to know about haemato-oncology
Blood Cancer UK have designed an RCN-accredited, free course for new starters and ward nurses on the haematology ward. This course is comprised of 10 chapters. It provides an opportunity to build on basic haemato-oncological concepts to support a foundation of nursing practice for those caring for people with blood cancer.
At the outset of the Covid-19 pandemic everyone rose to the challenge; in the health and care sector people did whatever it took to keep their teams and service afloat. Three months later the trajectory of the pandemic remains unclear and people are beginning to realise that we’re in this for the long haul.
Multiple sessions being run in late 2020 - https://www.healthcareconferencesuk.co.uk/conferences-masterclasses/subjects/cancer-care-and-oncology
ReIMAGINE consists of multiple clinical studies jointly funded by the Medical Research Council and Cancer Research UK. For the first time biomarkers (blood, urine and tissue) will be combined with state-of-the-art imaging (MRI scans) to predict which prostate cancers are likely to progress over time and which will not.
Chaired by UKONS board member Lisa Barrott, this forum will allow attendees to engage virtually with other immunology services from across the country and take the time to develop knowledge of assessing, managing and treating adverse side effects and toxicities. Plus, focus on how to pass experience and understanding onto colleagues, working in the community and in ED, to improve the management of immunotherapy.